Epidemiology of non-alcoholic fatty liver disease in China

Angulo, 2007, GI epidemiology: nonalcoholic fatty liver disease, Aliment Pharmacol Ther, 25, 883, 10.1111/j.1365-2036.2007.03246.x Williams, 2006, Global changes in liver disease, Hepatology, 44, 521, 10.1002/hep.21347 Amarapurkar, 2007, Asia-Pacific Working Party for NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?, J Gastroenterol Hepatol, 22, 788, 10.1111/j.1440-1746.2007.05042.x Wu, 2006, Overweight and obesity in China. The once lean giant has a weight problem that is increasing rapidly, BMJ, 19, 362, 10.1136/bmj.333.7564.362 Gu, 2005, Prevalence of the metabolic syndrome and overweight among adults in China, Lancet, 365, 1398, 10.1016/S0140-6736(05)66375-1 Fan, 2007, Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?, J Gastroenterol Hepatol, 22, 794, 10.1111/j.1440-1746.2007.04952.x Liu, 2007, Hepatitis B in China, Lancet, 369, 1582, 10.1016/S0140-6736(07)60723-5 Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 Yajima, 1983, Ultrasonographic diagnosis of fatty liver: significance of the liver–kidney contrast, Tohoku J Exp Med, 139, 43, 10.1620/tjem.139.43 Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003;11:71. Zeng, 2008, Guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease, J Dig Dis, 9, 108, 10.1111/j.1751-2980.2008.00331.x Farrell, 2007, Asia-Pacific Working Party for NAFLD Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary, J Gastroenterol Hepatol, 22, 775, 10.1111/j.1440-1746.2007.05002.x Liew, 2006, Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease, Obes Surg, 16, 1584, 10.1381/096089206779319392 Fan, 2001, Steatohepatitis studies in China, Shijie Huaren Xiaohua Zazhi, 9, 6 Zhang, 2004, Advances in the epidemiological study of fatty liver, Zhonghua Liu Xing Bing Xue Za Zhi, 25, 630 Fan, 2007, Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies, Hepatobiliary Pancreat Dis Int, 6, 572 Deurenberg, 2002, Aisians are different from Caucasians and from each other in their body mass index/body fat percent relationship, Obes Rev, 3, 141, 10.1046/j.1467-789X.2002.00065.x Fan, 2005, Prevalence of and risk factors for fatty liver in a general population of Shanghai, China, J Hepatol, 43, 508, 10.1016/j.jhep.2005.02.042 Zhou, 2007, Prevalence of fatty liver disease and its risk factors in the population of South China, World J Gastroenterol, 13, 6419, 10.3748/wjg.v13.i47.6419 Li, 2005, Alcoholism and alcoholic liver disease: focusing on epidemiological investigation in Asia, Hepatobiliary Pancreat Dis Int, 4, 170 Yiu, 2004, Epidemiological study: nonalcoholic fatty liver disease in Hong Kong Chinese, Hepatology, 40, 582A Chen, 2006, Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults, J Clin Gastroenterol, 40, 745, 10.1097/00004836-200609000-00016 Fan, 2007, The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers, J Gastroenterol Hepatol, 22, 663, 10.1111/j.1440-1746.2007.04892.x Wang, 2007, Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China, Postgrad Med J, 83, 192, 10.1136/pgmj.2006.052258 Chen, 2007, Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan, J Gastroenterol Hepatol, 22, 1482, 10.1111/j.1440-1746.2006.04615.x Fan, 1998, Analysis of risk factors for fatty liver, Zhonghua Yifengyixue Zazhi, 32, 189 Zhou, 2007, Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes, Zhonghua Yi Xue Za Zhi, 87, 2249 Hu, 2006, Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease, Nan Fang Yi Ke Da Xue Xue Bao, 26, 853 Huang, 2007, Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects, Obes Surg, 17, 1457, 10.1007/s11695-008-9423-0 Fan, 2005, Fatty liver and the metabolic syndrome among Shanghai adults, J Gastroenterol Hepatol, 20, 1825, 10.1111/j.1440-1746.2005.04058.x Wong, 2006, Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 4, 1154, 10.1016/j.cgh.2006.06.011 Hui, 2004, Beyond insulin resistance in NASH: TNF-alpha or adiponectin?, Hepatology, 40, 46, 10.1002/hep.20280 Wong, 2006, Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 24, 1215, 10.1111/j.1365-2036.2006.03112.x Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 Fan, 2008, VAT fat is bad for the liver, SAT fat is not!, J Gastroenterol Hepatol, 23, 829, 10.1111/j.1440-1746.2008.05474.x Liu, 2006, Mesenteric fat thickness as an independent determinant of fatty liver, Int J Obes (Lond), 30, 787, 10.1038/sj.ijo.0803201 Vega, 2007, Metabolic correlates of nonalcoholic fatty liver in women and men, Hepatology, 46, 716, 10.1002/hep.21727 Fan, 2001, Clinical epidemiology on relationship of fatty liver with viral hepatitis, Shanghai Yixue, 24, 119 Hui, 2008, Effect of peroxisome proliferator-activated receptors-γ and co-activator-1α genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people, Liver Int, 28, 385, 10.1111/j.1478-3231.2007.01623.x Wong, 2008, Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese, J Gastroenterol Hepatol, 23, 914, 10.1111/j.1440-1746.2008.05344.x Fueki, 2007, Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity, Clin Chim Acta, 382, 71, 10.1016/j.cca.2007.03.027 Freiberg, 2004, Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey, Diabetes Care, 27, 2954, 10.2337/diacare.27.12.2954 Fan, 2008, A population-based study of alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation, World J Gastroenterol, 14, 2418, 10.3748/wjg.14.2418 Fung, 2007, Etiologies of chronic liver diseases in Hong Kong, Eur J Gastroenterol Hepatol, 19, 659, 10.1097/MEG.0b013e3281ace0b7 Lang, 2003, A clinicopathological study on nonalcoholic steatohepatitis, Zhonghua Gan Zang Bing Za Zhi, 11, 81 George, 2005, Practical approach to the diagnosis and management of people with fatty liver diseases, 181 Hui, 2005, Histological progression of non-alcoholic fatty liver disease in Chinese patients, Aliment Pharmacol Ther, 21, 407, 10.1111/j.1365-2036.2005.02334.x Zheng, 2006, A clinical and pathological study of nonalcoholic fatty liver disease, Zhonghua Gan Zang Bing Za Zhi, 14, 449 Jin, 2005, Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients, Hepatobiliary Pancreat Dis Int, 4, 389 Pan, 2003, Pathological and clinical analysis of nonalcoholic steatohepatitis, Zhonghua Gan Zang Bing Za Zhi, 11, 384 Tang, 2006, Nonalcoholic fatty liver disease manifesting esophageal variceal bleeding, J Chin Med Assoc, 69, 175, 10.1016/S1726-4901(09)70201-1 Farrell, 2008, Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressing, J Gastroenterol Hepatol, 23, 508, 10.1111/j.1440-1746.2008.05379.x Qian, 2005, Obesity, fatty liver and liver cancer, Hepatobiliary Pancreat Dis Int, 4, 173 Fan, 2007, Effects of nonalcoholic fatty liver disease on the development of metabolic disorders, J Gastroenterol Hepatol, 22, 1086, 10.1111/j.1440-1746.2006.04781.x Chitturi, 2007, Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health, J Gastroenterol Hepatol, 22, 967, 10.1111/j.1440-1746.2007.04995.x Fan, 2008, Impact of non-alcoholic fatty liver disease on accelerated metabolic complications, J Dig Dis, 9, 63, 10.1111/j.1751-2980.2008.00323.x Bjornsson, 2007, Hepatitis C and steatosis, Arch Med Res, 38, 621, 10.1016/j.arcmed.2006.09.001 Fan, 2008, Hepatitis B and fatty liver: causal or coincidental?, J Gastroenterol Hepatol, 23, 679, 10.1111/j.1440-1746.2008.05361.x Jian-Wu, 2006, Effects of fatty liver and related factors on the efficacy of combination antiviral therapy in patients with chronic hepatitis C, Liver Int, 26, 166, 10.1111/j.1478-3231.2005.01219.x Hsing, 2008, Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China, Int J Cancer, 122, 1849, 10.1002/ijc.23251 Leung, 2006, Viral hepatitis C in Hong Kong, Intervirology, 49, 23, 10.1159/000087259 Shi, 2008, Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B, J Hepatol, 48, S342, 10.1016/S0168-8278(08)60915-0 Shi, 2008, Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection, J Gastroenterol Hepatol, 23, 1419, 10.1111/j.1440-1746.2008.05531.x Shen, 2003, Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey, World J Gastroenterol, 9, 1106, 10.3748/wjg.v9.i5.1106 Luo, 2007, Association of metabolic syndrome and hepatitis B infection in a Chinese population, Clin Chim Acta, 380, 238, 10.1016/j.cca.2007.01.012 Jan, 2006, A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10), Int J Obes (Lond), 30, 794, 10.1038/sj.ijo.0803204